As Quest Diagnostics (DGX) Share Price Rose, Polaris Capital Management Boosted Holding; Bank Of The Ozarks (OZRK) Share Value Declined While Sirios Capital Management LP Trimmed Stake

January 14, 2018 - By Richard Conner

John Brennan decreased its stake in Bank Of The Ozarks (OZRK) by 37.04% based on its latest 2017Q3 regulatory filing with the SEC. Sirios Capital Management LP sold 201,558 shares as the company’s stock declined 14.66% while stock markets rallied. The hedge fund run by John Brennan held 342,590 shares of the major banks company at the end of 2017Q3, valued at $16.46 million, down from 544,148 at the end of the previous reported quarter. Sirios Capital Management LP who had been investing in Bank Of The Ozarks for a number of months, seems to be less bullish one the $6.78B market cap company. The stock decreased 0.06% or $0.03 during the last trading session, reaching $52.47. About 1.48 million shares traded or 50.51% up from the average. Bank of the Ozarks (NASDAQ:OZRK) has risen 26.77% since January 14, 2017 and is uptrending. It has outperformed by 10.07% the S&P500.

Bernard Horn increased its stake in Quest Diagnostics (DGX) by 8.83% based on its latest 2017Q3 regulatory filing with the SEC. Polaris Capital Management Llc bought 30,600 shares as the company’s stock rose 10.72% with the market. The hedge fund run by Bernard Horn held 377,297 shares of the medical specialities company at the end of 2017Q3, valued at $35.33M, up from 346,697 at the end of the previous reported quarter. Polaris Capital Management Llc who had been investing in Quest Diagnostics for a number of months, seems to be bullish on the $13.85 billion market cap company. The stock increased 0.60% or $0.61 during the last trading session, reaching $101.63. About 588,136 shares traded. Quest Diagnostics Incorporated (NYSE:DGX) has risen 39.04% since January 14, 2017 and is uptrending. It has outperformed by 22.34% the S&P500.

Among 21 analysts covering Quest Diagnostics (NYSE:DGX), 7 have Buy rating, 2 Sell and 12 Hold. Therefore 33% are positive. Quest Diagnostics had 57 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has “Neutral” rating given on Thursday, October 22 by Mizuho. Wells Fargo maintained Quest Diagnostics Incorporated (NYSE:DGX) rating on Friday, October 20. Wells Fargo has “Market Perform” rating and $86 target. The firm earned “Hold” rating on Thursday, October 19 by Jefferies. Mizuho maintained it with “Buy” rating and $122 target in Monday, June 5 report. Citigroup maintained it with “Neutral” rating and $98 target in Friday, October 20 report. The firm has “Hold” rating given on Tuesday, August 18 by Zacks. Mizuho maintained Quest Diagnostics Incorporated (NYSE:DGX) on Wednesday, April 26 with “Buy” rating. Credit Suisse maintained Quest Diagnostics Incorporated (NYSE:DGX) rating on Thursday, September 28. Credit Suisse has “Hold” rating and $99.0 target. UBS upgraded Quest Diagnostics Incorporated (NYSE:DGX) rating on Monday, November 14. UBS has “Buy” rating and $90 target. The firm has “Sector Perform” rating given on Friday, January 29 by RBC Capital Markets.

Since August 4, 2017, it had 0 buys, and 6 sales for $17.85 million activity. STANZIONE DANIEL had sold 3,803 shares worth $410,762 on Tuesday, September 5. Davis J. E. sold $6.30M worth of Quest Diagnostics Incorporated (NYSE:DGX) on Tuesday, January 2. The insider LEIDEN JEFFREY M sold $31,571.

Investors sentiment decreased to 0.98 in Q3 2017. Its down 0.01, from 0.99 in 2017Q2. It dived, as 51 investors sold DGX shares while 184 reduced holdings. 57 funds opened positions while 173 raised stakes. 116.90 million shares or 2.64% more from 113.89 million shares in 2017Q2 were reported. Evercore Wealth Management Limited Liability Co holds 0% or 160 shares. Marshall Wace Ltd Liability Partnership holds 0.03% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX) for 7,352 shares. Invesco Ltd, Georgia-based fund reported 1.48M shares. Alliancebernstein LP reported 0.11% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Horizon Investments Limited Liability, North Carolina-based fund reported 5,803 shares. Monroe State Bank & Tru Mi stated it has 131 shares. Natixis holds 22,877 shares. Hancock Company holds 0.06% or 15,127 shares. Btim Corp stated it has 18,900 shares or 0.03% of all its holdings. 456 are owned by Alpha Windward Ltd. Omers Administration accumulated 29,793 shares. Endurance Wealth Mgmt owns 600 shares. Transamerica Finance Advsr accumulated 5,485 shares. Colonial Trust owns 68,838 shares for 1.42% of their portfolio. Barrow Hanley Mewhinney & Strauss Lc accumulated 509 shares.

Analysts await Bank of the Ozarks (NASDAQ:OZRK) to report earnings on January, 16. They expect $0.75 earnings per share, up 4.17% or $0.03 from last year’s $0.72 per share. OZRK’s profit will be $96.88M for 17.49 P/E if the $0.75 EPS becomes a reality. After $0.75 actual earnings per share reported by Bank of the Ozarks for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 12 analysts covering Bank of the Ozarks (NASDAQ:OZRK), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Bank of the Ozarks had 31 analyst reports since August 25, 2015 according to SRatingsIntel. The stock has “Overweight” rating by PiperJaffray on Thursday, October 5. The firm has “Outperform” rating by Raymond James given on Thursday, October 12. As per Wednesday, July 5, the company rating was maintained by Keefe Bruyette & Woods. On Monday, October 23 the stock rating was maintained by Brean Capital with “Buy”. The company was upgraded on Wednesday, August 26 by Sandler O’Neill. The firm earned “Buy” rating on Thursday, December 21 by Keefe Bruyette & Woods. The firm has “Buy” rating by Brean Capital given on Tuesday, January 2. Brean Capital maintained Bank of the Ozarks (NASDAQ:OZRK) on Friday, December 1 with “Buy” rating. The stock of Bank of the Ozarks (NASDAQ:OZRK) has “Outperform” rating given on Thursday, December 24 by Merion Capital Group. The rating was upgraded by Piper Jaffray to “Overweight” on Friday, May 6.

Investors sentiment decreased to 1.08 in 2017 Q3. Its down 0.23, from 1.31 in 2017Q2. It turned negative, as 42 investors sold OZRK shares while 102 reduced holdings. 46 funds opened positions while 109 raised stakes. 104.17 million shares or 2.52% less from 106.85 million shares in 2017Q2 were reported. Raymond James And Assoc reported 0.09% in Bank of the Ozarks (NASDAQ:OZRK). The New York-based Blackrock has invested 0.03% in Bank of the Ozarks (NASDAQ:OZRK). 760 were accumulated by Bessemer Grp Inc Inc Inc. Fincl Bank Of Montreal Can reported 0.02% in Bank of the Ozarks (NASDAQ:OZRK). Benjamin F Edwards invested in 2,054 shares. Contravisory Invest Management holds 0% or 20 shares. Ls Advisors Llc accumulated 85,906 shares or 0.25% of the stock. Shaker Oh accumulated 82,610 shares or 2.77% of the stock. Credit Suisse Ag stated it has 91,330 shares. Advantus Capital invested in 0.02% or 15,330 shares. Forte Capital Limited Liability Adv has 56,317 shares for 0.87% of their portfolio. Cim Inv Mangement Incorporated owns 8,127 shares for 0.14% of their portfolio. Invesco Limited holds 839,506 shares or 0.01% of its portfolio. Teacher Retirement Sys Of Texas has 10,043 shares. Cortina Asset Management Ltd Liability Corporation reported 0.91% of its portfolio in Bank of the Ozarks (NASDAQ:OZRK).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>